<p>泰格醫藥 (03347.HK) +0.280 (+0.777%) 空頭頭寸 $21.04M; 比率 8.028% 宣佈計劃在 12 個月內使用自有資金或自籌資金，通過集中競價交易回購部分 A 股。回購的股份將用於後續實施 A 股股權激勵計劃或 A 股員工持股計劃，以及減少公司的註冊資本。總回購金額不低於人民幣 5 億元且不超過人民幣 10 億元，回購價格不超過人民幣 60 元每股。(ha/u)(香港股票報價延遲至少 15 分鐘。空頭數據截至 2026-05-13 16:25.)</p>

泰格醫藥

<p>泰格醫藥宣佈計劃在 12 個月內回購價值在 5 億至 10 億人民幣之間的 A 股。此次回購將通過其自有資金或自籌資金通過集中競價交易進行。回購的股份將用於 A 股股權激勵計劃、員工持股計劃，以及減少註冊資本，回購價格最高為每股 60 人民幣</p>

<p>TIGERMED (03347.HK) +0.280 (+0.777%)  Short selling $21.04M; Ratio 8.028%  announced that it plans to use its own funds or self-raised funds within 12 months to repurchase part of its A shares through centralized bidding transactions. The repurchased shares will be used for the subsequent implementation of A-share equity incentive schemes or A-share employee share ownership plans, as well as to reduce the companys registered capital. The total repurchase amount will be no less than RMB500 million and no more than RMB1 billion, with the repurchase price not exceeding RMB60 per share. (ha/u)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-13 16:25.)</p>
<div class="lb-trans"><p>泰格醫藥 (03347.HK) +0.280 (+0.777%) 空頭頭寸 $21.04M; 比率 8.028% 宣佈計劃在 12 個月內使用自有資金或自籌資金，通過集中競價交易回購部分 A 股。回購的股份將用於後續實施 A 股股權激勵計劃或 A 股員工持股計劃，以及減少公司的註冊資本。總回購金額不低於人民幣 5 億元且不超過人民幣 10 億元，回購價格不超過人民幣 60 元每股。(ha/u)(香港股票報價延遲至少 15 分鐘。空頭數據截至 2026-05-13 16:25.)</p>
</div>

泰格醫藥計劃最多花費人民幣 10 億元用於回購 A 股